Home / Compliance actions / 619233

FDA Warning Letter — Cooper Institute for Advanced Reproductive Medicine

Case 619233 — FEI 3011006339

The FDA took a Warning Letter action against Cooper Institute for Advanced Reproductive Medicine on November 15, 2021 (Houston, TX). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Cooper Institute for Advanced Reproductive Medicine
Date
November 15, 2021
Fiscal Year
2022
Product Type
Biologics
Center
CBER
Location
Houston, TX (United States)

Facility

Recent inspections

  • 1223634 (OAI Thu Nov 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1192782 (NAI Fri Dec 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1146456 (OAI Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1017306 (NAI Wed Apr 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 907753 (VAI Mon Dec 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources